|Day Low/High||40.88 / 41.08|
|52 Wk Low/High||31.43 / 48.25|
Which stocks will be most favored by the corporate-bond purchases?
This market is like a leaky helium balloon; watch out for sudden downdrafts.
The pharmaceutical giant is teaming up with Google's parent with as much as $715 million in joint investments.
GlaxoSmithKline and Google's parent Alphabet announced their joint plan to pioneer a new form of electronic medical treatment.
The U.K. isn't going anywhere Brexit vote notwithstanding, and here's a way to get on the most business-friendly state across the pond.
If you think the best thing to do post-Brexit is buy more, here are 4 to consider.
GSK has been largely stuck between $44 on the upside and $37 on the downside for the past 12 months.
The expected legal deluge will be manageable thanks to JNJ's massive size and financial strength.
Jim Cramer says it you are going to own a drug stock, invest in Allergan or Johnson & Johnson.
Jim Cramer says UnitedHealth's stock is going much higher, and it is a 'terrific' name to own.
Shares of GlaxoSmithKline are up a pleasant 5% in 2016 and it currently sports a healthy 6.5% dividend yield.
CEO Read says the Viagra maker retains the means to pursue 'attractive business development' opportunities as he tears up the six-month-old deal with the maker of Botox.
Pfizer scored the top spot in Interbrand Health's inaugural ranking of the top ten biopharmaceutical brands.
With the short-term trend neutral and the longer-term trend down be on guard for a break lower to around $35.
Owning GSK May calls may give a nice payout on any good news regarding a Zika virus vaccine.
If you have an appetite for risk, there are buying opportunities.
Cempra and Relypsa are two high-risk, high-reward small-caps worth considering.
Stocks were sharply lower at midday in a volatile session to end the week.
This trio enjoys competitive advantages that should serve investors well over the long haul.
The stock has put in a tradable low that can support a respectable rally that could carry into early 2016.
For Wednesday October 28, TheStreet awaits quarterly results from Walgreens Boots Alliance (WBA), Mondelez (MDLZ), Fiat Chrysler (FCAU), Amgen (AMGN), PayPal (PYPL), Buffalo Wild Wings (BWLD) and more.
Eli Lilly has bucked the downtrend in other pharma names, and its chart is pointed higher.
U.S. stocks open sharply higher Wednesday. Wall Street followed a 7.7 percent gain in Japan's Nikkei Stock Index, the biggest percentage gain since October 2008.
Not many, according to filings from Tweedy Browne and Kahn Brothers.